Keay Nakae
Stock Analyst at Chardan Capital
(3.14)
# 2,608
Out of 4,835 analysts
596
Total ratings
39%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: ALSEN Sensorion SA | Reiterated: Buy | €1.00 | €0.23 | +336.68% | 2 | Sep 4, 2026 | |
| HIND Vyome Holdings | Initiated Coverage: Buy | $3.5 | $2.10 | +66.67% | 1 | Sep 3, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $3.48 | +216.09% | 1 | Sep 1, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $7 | $3.35 | +108.96% | 1 | Aug 25, 2026 | |
| SLN Silence Therapeutics | Reiterated: Buy | n/a | $13.31 | - | 19 | Aug 16, 2026 | |
| PMN ProMIS Neurosciences | Reiterated: Buy | $20 → $33 | $13.40 | +146.27% | 2 | Aug 13, 2026 | |
| MGX Metagenomi Therapeutics | Reiterated: Buy | $5 | $1.16 | +331.03% | 2 | Aug 10, 2026 | |
| BME: PHM Pharma Mar, S.A. | Reiterated: Buy | €100.00 | €76.50 | +30.72% | 9 | Aug 9, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $15 | $13.06 | +14.85% | 6 | Aug 6, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $115 | $82.76 | +38.96% | 49 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $29.34 | +19.29% | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $38 | $18.42 | +106.30% | 20 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €0.08 | €0.11 | -27.93% | 3 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.23 | +308.16% | 7 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $1.94 | +54.64% | 40 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $16 | $3.42 | +367.84% | 20 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6.5 | $4.34 | +49.77% | 1 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $4.52 | +209.73% | 19 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $247.51 | +71.71% | 51 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $31.68 | -5.30% | 4 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥800 | ¥284 | +181.69% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.81 | +244.23% | 12 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $45 | $1.17 | +3,746.15% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.50 | +7,900.00% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €10.00 → €5.00 | €0.73 | +589.66% | 5 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $85 | $109.96 | -22.70% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $6 | $5.10 | n/a | 19 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $0.3769 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.43 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.00001 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.74 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.22 | n/a | 20 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.5 → $5 | $5.12 | n/a | 47 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.71 | n/a | 7 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $2.74 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.50 | n/a | 16 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.72 | n/a | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.87 | n/a | 31 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.30 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.75 | n/a | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $50 | $0.0001 | n/a | 8 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.37 | n/a | 15 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.39 | n/a | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.98 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,452.00 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.02 | n/a | 15 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.64 | n/a | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4.5 | $1.03 | n/a | 9 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6829 | n/a | 2 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 | $3.98 | n/a | 11 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $136.62 | n/a | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 2 | Jan 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.88 | n/a | 1 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $22.29 | n/a | 3 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.3 → $4.5 | $0.7402 | n/a | 3 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.58 | n/a | 3 | Dec 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $6.60 | n/a | 1 | Aug 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 | $2.04 | n/a | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 → $2 | $0.0001 | n/a | 4 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $1.46 | n/a | 4 | Mar 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.46 | n/a | 1 | Dec 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $2.39 | n/a | 1 | Aug 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $18 | $0.0005 | n/a | 3 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $3.90 | n/a | 1 | Oct 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.0001 | n/a | 1 | Jul 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.3 | $0.2427 | n/a | 1 | Jun 25, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $37.87 | n/a | 1 | May 16, 2012 |
Sensorion SA
Sep 4, 2026
Reiterated: Buy
Price Target: €1.00
Current: €0.23
Upside: +336.68%
Vyome Holdings
Sep 3, 2026
Initiated Coverage: Buy
Price Target: $3.5
Current: $2.10
Upside: +66.67%
Rocket Pharmaceuticals
Sep 1, 2026
Reiterated: Buy
Price Target: $11
Current: $3.48
Upside: +216.09%
Prime Medicine
Aug 25, 2026
Reiterated: Buy
Price Target: $7
Current: $3.35
Upside: +108.96%
Silence Therapeutics
Aug 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.31
Upside: -
ProMIS Neurosciences
Aug 13, 2026
Reiterated: Buy
Price Target: $20 → $33
Current: $13.40
Upside: +146.27%
Metagenomi Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
Pharma Mar, S.A.
Aug 9, 2026
Reiterated: Buy
Price Target: €100.00
Current: €76.50
Upside: +30.72%
Korro Bio
Aug 6, 2026
Reiterated: Buy
Price Target: $15
Current: $13.06
Upside: +14.85%
Arrowhead Pharmaceuticals
Aug 4, 2026
Reiterated: Buy
Price Target: $115
Current: $82.76
Upside: +38.96%
Aug 3, 2026
Reiterated: Buy
Price Target: $35
Current: $29.34
Upside: +19.29%
Jul 29, 2026
Reiterated: Buy
Price Target: $40 → $38
Current: $18.42
Upside: +106.30%
Jul 15, 2026
Reiterated: Hold
Price Target: €0.08
Current: €0.11
Upside: -27.93%
Jul 1, 2026
Reiterated: Buy
Price Target: $5
Current: $1.23
Upside: +308.16%
Jun 25, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.94
Upside: +54.64%
Jun 16, 2026
Reiterated: Buy
Price Target: $14 → $16
Current: $3.42
Upside: +367.84%
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $6.5
Current: $4.34
Upside: +49.77%
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $4.52
Upside: +209.73%
May 1, 2026
Reiterated: Buy
Price Target: $425
Current: $247.51
Upside: +71.71%
Apr 21, 2026
Reiterated: Buy
Price Target: $30
Current: $31.68
Upside: -5.30%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: ¥800
Current: ¥284
Upside: +181.69%
Mar 12, 2026
Reiterated: Buy
Price Target: $20
Current: $5.81
Upside: +244.23%
Feb 24, 2026
Upgraded: Buy
Price Target: $2.5 → $45
Current: $1.17
Upside: +3,746.15%
Jan 5, 2026
Reiterated: Buy
Price Target: $40
Current: $0.50
Upside: +7,900.00%
Sep 30, 2025
Reiterated: Buy
Price Target: €10.00 → €5.00
Current: €0.73
Upside: +589.66%
Sep 25, 2025
Reiterated: Buy
Price Target: $60 → $85
Current: $109.96
Upside: -22.70%
May 8, 2025
Downgraded: Hold
Price Target: $25 → $6
Current: $5.10
Upside: n/a
Dec 20, 2024
Reiterated: Hold
Price Target: $12
Current: $0.3769
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $11.43
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.74
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.22
Upside: n/a
Nov 19, 2024
Reiterated: Buy
Price Target: $4.5 → $5
Current: $5.12
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $6
Current: $1.71
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $10 → $8
Current: $2.74
Upside: n/a
Mar 14, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 12, 2023
Rated: Hold
Price Target: n/a
Current: $15.50
Upside: n/a
Mar 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $10.72
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $5.87
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $9.30
Upside: n/a
Feb 6, 2023
Reiterated: Buy
Price Target: n/a
Current: $8.75
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $100 → $50
Current: $0.0001
Upside: n/a
Sep 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $9.39
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $13.98
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $2,452.00
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.02
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.64
Upside: n/a
Jun 10, 2021
Reiterated: Hold
Price Target: $8 → $4.5
Current: $1.03
Upside: n/a
Nov 20, 2020
Rated: Hold
Price Target: n/a
Current: $0.6829
Upside: n/a
Jul 30, 2020
Rated: Hold
Price Target: $2
Current: $3.98
Upside: n/a
Mar 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $136.62
Upside: n/a
Jan 28, 2020
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $10.88
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $22.29
Upside: n/a
Feb 16, 2017
Reiterated: Buy
Price Target: $3.3 → $4.5
Current: $0.7402
Upside: n/a
Dec 6, 2016
Reiterated: Buy
Price Target: $6
Current: $2.58
Upside: n/a
Aug 23, 2016
Reiterated: Buy
Price Target: $4
Current: $6.60
Upside: n/a
Aug 12, 2016
Reiterated: Buy
Price Target: $2.25
Current: $2.04
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $2.25 → $2
Current: $0.0001
Upside: n/a
Mar 28, 2016
Reiterated: Buy
Price Target: $12 → $6
Current: $1.46
Upside: n/a
Dec 3, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $1.46
Upside: n/a
Aug 6, 2014
Downgraded: Hold
Price Target: $4
Current: $2.39
Upside: n/a
May 15, 2014
Downgraded: Hold
Price Target: $100 → $18
Current: $0.0005
Upside: n/a
Oct 7, 2013
Initiated Coverage: Buy
Price Target: $13
Current: $3.90
Upside: n/a
Jul 3, 2013
Reiterated: Buy
Price Target: $5.5
Current: $0.0001
Upside: n/a
Jun 25, 2013
Initiated Coverage: Buy
Price Target: $2.3
Current: $0.2427
Upside: n/a
May 16, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $37.87
Upside: n/a